This application note explores how an advanced 5 L single-use bioreactor enhances productivity, reduces costs and enables ...
YOKOHAMA, Japan & SEATTLE--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, today announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, ...
The perfusion bioreactors market is booming due to rising biopharmaceutical demand, innovations in bioreactor design, and regulatory support. Key opportunities include smaller-scale systems for R&D ...
The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR ®) single-use systems to Eli ...
This infographic highlights how bench-scale single-use bioreactors help overcome these barriers with efficiency, flexibility ...
The biopharmaceutical and biotech industries face mounting challenges in regulated environments, including rising drug development costs, strict regulatory demands, and the need for scalable, ...
WuXi Biologics completed the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000 L single-use bioreactors (SUBs) in the second drug substance line of ...
WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the successful completion of the first commercial project Process ...
The global Single-use Bioprocessing Market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to ...
Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results